Oxford Asset Management’s Zimmer Biomet ZBH Stock Holding History

Oxford Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,552	Closed	-$589K	–	744
2025 Q4	$589K	Buy	+6,552	New	+$621K	0.22%	156
2025 Q1	–	Sell	-4,894	Closed	-$517K	–	733
2024 Q4	$517K	Buy	+4,894	New	+$525K	0.23%	146
2020 Q1	–	Sell	-13,156	Closed	-$1.91M	–	1348
2019 Q4	$1.91M	Buy	13,156 +8,550	+186%	+$1.18M	0.05%	445
2019 Q3	$614K	Sell	4,606 -82,634	-95%	-$10.7M	0.01%	1177
2019 Q2	$9.97M	Buy	87,240 +61,162	+235%	+$7.16M	0.21%	95
2019 Q1	$3.23M	Buy	26,078 +17,426	+201%	+$1.98M	0.07%	358
2018 Q4	$871K	Sell	8,652 -4,249	-33%	-$478K	0.02%	936
2018 Q3	$1.64M	Buy	+12,901	New	+$1.53M	0.03%	776
2017 Q4	–	Sell	-15,017	Closed	-$1.69M	–	1896
2017 Q3	$1.69M	Buy	+15,017	New	+$1.73M	0.03%	708
2017 Q2	–	Sell	-46,075	Closed	-$5.46M	–	1730
2017 Q1	$5.46M	Buy	+46,075	New	+$5.22M	0.13%	136

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oxford Asset Management's ZBH Position: Q1 2026 in Review

Oxford Asset Management sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 6,552 shares — an estimated $589K sold.

Oxford Asset Management first reported a position in ZBH in Q1 2017 and held it in 10 quarters. The position peaked at $9.97M in Q2 2019. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Oxford Asset Management reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
Oxford Asset Management sold 6,552 Zimmer Biomet shares in Q1 2026, an estimated $589K.
Oxford Asset Management first reported a position in Zimmer Biomet in Q1 2017 and held it in 10 quarters.
Oxford Asset Management's Zimmer Biomet position peaked at $9.97M in Q2 2019.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Oxford Asset Management's 13F filing for Q1 2026, filed 15 May 2026.